Literature DB >> 23344743

Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2.

Kwang-Dong Choi1, Ji-Won Yook, Min-Ji Kim, Hyang-Sook Kim, Young-Eun Park, Ji Soo Kim, Jae-Hwan Choi, Jin-Hong Shin, Dae-Seong Kim.   

Abstract

Anticipation is a phenomenon characterized by decreasing age at onset and increasing severity of symptoms of a disease in successive generations within a pedigree. Anticipation mostly occurs in neurodegenerative diseases with expansion of unstable trinucleotide repeats. However, it has not been previously pointed out in episodic ataxia type 2 (EA2). Clinical and genetic analyses were performed in nine members from three consecutive generations of a Korean family with EA2. We performed a polymerase chain reaction (PCR)-based direct sequence analysis of all coding regions of CACNA1A using genomic DNA. The clinically affected family members showed recurrent vertigo, interictal nystagmus, and childhood epilepsy. There is a decrease in the age onset (possible genetic anticipation) in three succeeding generations of the family. Genetic analysis identified a splice site mutation (p.Val1465Glyfs13X) and normal trinucleotide repeats in CACNA1A in all clinically affected and one unaffected members. Recognizing anticipation would aid in genetic counseling in EA2.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23344743     DOI: 10.1007/s10072-013-1298-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  13 in total

1.  Evidence for genetic anticipation in nodal osteoarthritis.

Authors:  G D Wright; M Regan; C M Deighton; G Wallis; M Doherty
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

2.  Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A.

Authors:  P Imbrici; L H Eunson; T D Graves; K P Bhatia; N H Wadia; D M Kullmann; M G Hanna
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

Review 3.  High mutation detection rate in TCOF1 among Treacher Collins syndrome patients reveals clustering of mutations and 16 novel pathogenic changes.

Authors:  A Splendore; E O Silva; L G Alonso; A Richieri-Costa; N Alonso; A Rosa; G Carakushanky; D P Cavalcanti; D Brunoni; M R Passos-Bueno
Journal:  Hum Mutat       Date:  2000-10       Impact factor: 4.878

4.  High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2.

Authors:  C Denier; A Ducros; K Vahedi; A Joutel; P Thierry; A Ritz; G Castelnovo; T Deonna; P Gérard; J L Devoize; A Gayou; B Perrouty; T Soisson; A Autret; J M Warter; A Vighetto; P Van Bogaert; S Alamowitch; E Roullet; E Tournier-Lasserve
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

5.  Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene.

Authors:  Ester Cuenca-León; Isabel Banchs; Selma A Serra; Pilar Latorre; Noèlia Fernàndez-Castillo; Roser Corominas; Miguel A Valverde; Víctor Volpini; José M Fernández-Fernández; Alfons Macaya; Bru Cormand
Journal:  J Neurol Sci       Date:  2009-02-20       Impact factor: 3.181

Review 6.  Primary episodic ataxias: diagnosis, pathogenesis and treatment.

Authors:  J C Jen; T D Graves; E J Hess; M G Hanna; R C Griggs; R W Baloh
Journal:  Brain       Date:  2007-06-15       Impact factor: 13.501

7.  Role for genetic anticipation in Lynch syndrome.

Authors:  Mef Nilbert; Susanne Timshel; Inge Bernstein; Klaus Larsen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

8.  Episodic Ataxia Type 2 due to a Deletion Mutation in the CACNA1A Gene in a Korean Family.

Authors:  Jeong-Min Kim; Ji Soo Kim; Chang-Seok Ki; Beom-Seok Jeon
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

9.  Decrease in the size of the myotonic dystrophy CTG repeat during transmission from parent to child: implications for genetic counselling and genetic anticipation.

Authors:  A G Hunter; P Jacob; K O'Hoy; I MacDonald; G Mettler; C Tsilfidis; R G Korneluk
Journal:  Am J Med Genet       Date:  1993-02-01

Review 10.  Episodic ataxia type 2.

Authors:  Michael Strupp; Andreas Zwergal; Thomas Brandt
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

View more
  5 in total

1.  Exercise-induced downbeat nystagmus in a Korean family with a nonsense mutation in CACNA1A.

Authors:  Jae-Hwan Choi; Jae-Deuk Seo; Yu Ri Choi; Min-Ji Kim; Jin-Hong Shin; Ji Soo Kim; Kwang-Dong Choi
Journal:  Neurol Sci       Date:  2015-03-18       Impact factor: 3.307

2.  Late-onset episodic ataxia associated with SLC1A3 mutation.

Authors:  Kwang-Dong Choi; Joanna C Jen; Seo Young Choi; Jin-Hong Shin; Hyang-Sook Kim; Hyo-Jung Kim; Ji-Soo Kim; Jae-Hwan Choi
Journal:  J Hum Genet       Date:  2016-11-10       Impact factor: 3.172

Review 3.  The electrophysiological footprint of CACNA1A disorders.

Authors:  Elisabetta Indelicato; Iris Unterberger; Wolfgang Nachbauer; Andreas Eigentler; Matthias Amprosi; Fiona Zeiner; Edda Haberlandt; Manuela Kaml; Elke Gizewski; Sylvia Boesch
Journal:  J Neurol       Date:  2021-02-05       Impact factor: 4.849

Review 4.  Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature.

Authors:  Wolfgang Nachbauer; Michael Nocker; Elfriede Karner; Iva Stankovic; Iris Unterberger; Andreas Eigentler; Rainer Schneider; Werner Poewe; Margarete Delazer; Sylvia Boesch
Journal:  J Neurol       Date:  2014-05       Impact factor: 4.849

Review 5.  Episodic Ataxias: Clinical and Genetic Features.

Authors:  Kwang-Dong Choi; Jae-Hwan Choi
Journal:  J Mov Disord       Date:  2016-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.